Evidence map›Paper›PMID 29198013›Full record

ArticleInflammation2018

Short- and Long-Term Protective Effects of Melatonin in a Mouse Model of Sepsis-Associated Encephalopathy.

Mu-Huo Ji, De-Guo Xia, Lan-Yue Zhu, Xia Zhu, Xiao-Yan Zhou, Jiang-Yan Xia, Jian-Jun Yang

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Mu-Huo JiDepartment of Anesthesiology, Jinling Clinical Medical College of Nanjing Medical University, Nanjing, China.
De-Guo XiaDepartment of Anesthesiology, Clinical Medical College of Yangzhou University (Subei People's Hospital of Jiangsu Province), Yangzhou, Jiangsu Province, China.
Lan-Yue ZhuDepartment of Anesthesiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, China.
Xia ZhuDepartment of Anesthesiology, Jinling Clinical Medical College of Nanjing Medical University, Nanjing, China.
Xiao-Yan ZhouDepartment of Anesthesiology, Jinling Clinical Medical College of Nanjing Medical University, Nanjing, China.
Jiang-Yan XiaDepartment of Anesthesiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, China.
Jian-Jun YangDepartment of Anesthesiology, Jinling Clinical Medical College of Nanjing Medical University, Nanjing, China. yjyangjj@126.com.
Nanjing Medical University · CNZhongda Hospital Southeast University · CNYangzhou University · CN

Funding

National Natural Science Foundation of China (CN) 81471105,81772126National Science Foundation of China 81771156
6 · The paper itself

Abstract

Brain dysfunction is a common complication after sepsis and is an independent risk factor for a poor prognosis, which is partly attributed to the dysregulated inflammatory response and oxidative damage. Melatonin regulates the sleep-wake cycle and also has potent anti-inflammatory and antioxidant properties, yet the protective effects of melatonin on sepsis-induced neurobehavioral dysfunction remain to be elucidated. In the present study, melatonin was administered intraperitoneally daily at a dose of 10 mg/kg for three consecutive days immediately (early treatment) or 7 days (delayed treatment) after sham operation or cecal ligation and puncture (CLP), followed by an additional treatment in drinking water until the end of behavioral tests. The concentrations of pro-inflammatory cytokines (tumor necrosis factor (TNF-α), interleukin-1β (IL-1β), IL-6, IL-10), malondialdehyde (MDA), superoxide dismutase (SOD), reactive oxygen species (ROS), brain-derived neurotrophic factor (BDNF), and glial cell line-derived neurotrophic factor (GDNF) were determined at the indicated time points. Compared with the CLP + vehicle group, we found that early melatonin treatment resulted in increased survival rate but not improvement in measures of neurobehavioral outcomes, which was accompanied by significantly lower plasma level of IL-1β. Intriguingly, delayed melatonin treatment improved neurobehavioral dysfunction by normalization of hippocampal BDNF and GDNF expressions. In conclusion, our study suggests the beneficial effects of both early and delayed melatonin treatment after sepsis development, which implicates melatonin has a potential therapeutic value in sepsis-associated organ damage including brain dysfunction.

Indexed as

AnimalsBehavior, AnimalBrain-Derived Neurotrophic FactorCytokinesGlial Cell Line-Derived Neurotrophic FactorHippocampusMelatoninMiceProtective AgentsSepsis-Associated EncephalopathySurvival RateTime FactorsBrain-Derived Neurotrophic FactorCytokinesGlial Cell Line-Derived Neurotrophic FactorMelatoninProtective Agentscognitive functionmelatoninneuroplasticitysepsis

Identifiers

PMID29198013
OpenAlexW2773024908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.